当前位置:
X-MOL 学术
›
Tetrahedron Lett.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Short enantioselective total synthesis of (+)-tofacitinib
Tetrahedron Letters ( IF 1.5 ) Pub Date : 2021-02-01 , DOI: 10.1016/j.tetlet.2021.152838 Kishor D. Mane , Rohit B. Kamble , Gurunath Suryavanshi
中文翻译:
(+)-托法替尼的短对映选择性全合成
更新日期:2021-03-04
Tetrahedron Letters ( IF 1.5 ) Pub Date : 2021-02-01 , DOI: 10.1016/j.tetlet.2021.152838 Kishor D. Mane , Rohit B. Kamble , Gurunath Suryavanshi
An enantioselective total synthesis of Tofacitinib (CP-690,550), a Janus tyrosine kinase (JAK3) specific inhibitor has been achieved from the readily available 4-piperidone. Proline catalysed hydroxylation is the key step for the synthesis of enantiopure 1-benzyl-4-methylpiperidin-3-ol.
中文翻译:
(+)-托法替尼的短对映选择性全合成
对映体选择性合成托法替尼(CP-690,550),一种Janus酪氨酸激酶(JAK3)特异性抑制剂,是从容易获得的4-哌啶酮中合成的。脯氨酸催化的羟基化反应是合成对映体纯的1-苄基-4-甲基哌啶-3-醇的关键步骤。